BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 9579822)

  • 1. No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees.
    Allen-Brady K; Farnham JM; Camp NJ; Karlins E; Ostrander EA; Cannon-Albright LA
    BMC Res Notes; 2009 May; 2():94. PubMed ID: 19476645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA2 in Ovarian Development and Function.
    Turchetti D; Zuntini R; Tricarico R; Bellacosa A
    N Engl J Med; 2019 Mar; 380(11):1086-1087. PubMed ID: 30865813
    [No Abstract]   [Full Text] [Related]  

  • 3. BRCA2 in Ovarian Development and Function.
    Qin Y; Zhang F; Chen ZJ
    N Engl J Med; 2019 Mar; 380(11):1086. PubMed ID: 30865812
    [No Abstract]   [Full Text] [Related]  

  • 4. Forth nightly review: hereditary ovarian carcinoma.
    Kasprzak L; Foulkes WD; Shelling AN
    BMJ; 1999 Mar; 318(7186):786-9. PubMed ID: 10082707
    [No Abstract]   [Full Text] [Related]  

  • 5. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
    Casey MJ; Bewtra C
    Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
    Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A missense mutation in the BRCA2 gene in three siblings with ovarian cancer.
    Roth S; Kristo P; Auranen A; Shayehgi M; Seal S; Collins N; Barfoot R; Rahman N; Klemi PJ; Grénman S; Sarantaus L; Nevanlinna H; Butzow R; Ashworth A; Stratton MR; Aaltonen LA
    Br J Cancer; 1998 Apr; 77(8):1199-202. PubMed ID: 9579822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
    Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
    J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
    Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
    Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the BRCA2 gene in ovarian carcinomas.
    Takahashi H; Chiu HC; Bandera CA; Behbakht K; Liu PC; Couch FJ; Weber BL; LiVolsi VA; Furusato M; Rebane BA; Cardonick A; Benjamin I; Morgan MA; King SA; Mikuta JJ; Rubin SC; Boyd J
    Cancer Res; 1996 Jun; 56(12):2738-41. PubMed ID: 8665505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
    Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
    Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.
    Rebbeck TR; Couch FJ; Kant J; Calzone K; DeShano M; Peng Y; Chen K; Garber JE; Weber BL
    Am J Hum Genet; 1996 Sep; 59(3):547-53. PubMed ID: 8751855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low proportion of BRCA2 mutations in Finnish breast cancer families.
    Vehmanen P; Friedman LS; Eerola H; Sarantaus L; Pyrhönen S; Ponder BA; Muhonen T; Nevanlinna H
    Am J Hum Genet; 1997 May; 60(5):1050-8. PubMed ID: 9150152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
    Struewing JP; Hartge P; Wacholder S; Baker SM; Berlin M; McAdams M; Timmerman MM; Brody LC; Tucker MA
    N Engl J Med; 1997 May; 336(20):1401-8. PubMed ID: 9145676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer.
    Whittemore AS; Gong G; Itnyre J
    Am J Hum Genet; 1997 Mar; 60(3):496-504. PubMed ID: 9042908
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.